Results 21 to 30 of about 1,370,177 (306)

Effects of dalcetrapib in patients with a recent acute coronary syndrome [PDF]

, 2012
In observational analyses, higher levels of high-density lipoprotein (HDL) cholesterol have been associated with a lower risk of coronary heart disease events.
Abt, Markus, Ballantyne, Christie M., Barter, Philip J., Brumm, Jochen, Chaitman, Bernard R., Colquhoun, David, Holme, Ingar M., Kallend, David, Leiter, Lawrence A., Leitersdorf, Eran, McMurray, John J. V., Mundl, Hardi, Nicholls, Stephen J., Olsson, Anders G., Schwartz, Gregory G., Shah, Prediman K., Tardif, Jean-Claude, The dal-OUTCOMES Investigators, Wright, R. Scott   +18 more
core   +2 more sources

Systolic Blood Pressure and Pulse Pressure Are Predictors of Future Cardiovascular Events in Patients with True Resistant Hypertension

Diagnostics, 2023
Given the increased risk of cardiovascular events associated with resistant hypertension, predictive cardiovascular prognosis is extremely important. Ambulatory blood pressure monitoring (ABPM) is mandatory for resistant hypertension diagnosis, but its ...
J. Mesquita Bastos, Lisa Ferraz, Flávio G. Pereira, Susana Lopes   +3 more
doaj   +1 more source

Circulating magnesium and cardiovascular events [PDF]

The American Journal of Clinical Nutrition, 2014
The association between circulating magnesium and cardiovascular events, and possible pathophysiological mechanisms.
Velat, Ivan, Čulić, Viktor
openaire   +3 more sources

Metabolic syndrome and cardiovascular risk after liver transplantation: a single-center experience. [PDF]

, 2012
Excessive weight gain, hypertension, hyperlipidemia, and diabetes are frequently observed among orthotopic liver transplantation (OLT) patients. These alterations, which are probably multifactorial in origin, contribute to posttransplantation metabolic ...
BERLOCO, Pasquale Bartolomeo, GIANNELLI, VALERIO, GINANNI CORRADINI, Stefano, GIUSTO, MICHELA, LAI, QUIRINO, M. Iadevaia, MERLI, Manuela, ROSSI, MASSIMO   +7 more
core   +1 more source

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer [PDF]

, 2007
Background Selective cyclooxygenase inhibitors may retard the progression of cancer, but they have enhanced thrombotic potential. We report on cardiovascular adverse events in patients receiving rofecoxib to reduce rates of recurrence of colorectal ...
Andrew Stanley, Christopher C. McConkey, Claire Iveson, David J. Kerr, Giovannucci E, Janet A. Dunn, Joanne C. Stokes, Justine L. Smith, Michael J. Langman, Oshima M, Patrick Julier, Rachel S.J. Midgley, Ravi Duvvuri, Thun MJ   +13 more
core   +1 more source

Risk Factors for Long-Term Coronary Artery Calcium Progression in the Multi-Ethnic Study of Atherosclerosis. [PDF]

, 2015
BackgroundCoronary artery calcium (CAC) detected by noncontrast cardiac computed tomography scanning is a measure of coronary atherosclerosis burden. Increasing CAC levels have been strongly associated with increased coronary events.
Blaha, Michael J, Budoff, Matthew, Gassett, Amanda J, Kaufman, Joel D, Kronmal, Richard, McClelland, Robyn L, Olives, Casey, Sheppard, Lianne   +7 more
core   +2 more sources

Cardio-Ankle Vascular Index is a predictor of cardiovascular events

Artery Research, 2011
Introduction: The Cardio-Ankle Vascular Index (CAVI) was established as a parameter of atherosclerosis that does not depend on a subject’s blood pressure, and is now used in many centers.
Yoshiaki Kubota, Daisuke Maebuchi, Makoto Takei, Yumiko Inui, Yuumi Sudo, Yukinori Ikegami, Jun Fuse, Munehisa Sakamoto, Yukihiko Momiyama   +8 more
doaj   +1 more source

Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. [PDF]

, 2014
OBJECTIVES: To examine associations between sarcopenia, obesity, and sarcopenic obesity and risk of cardiovascular disease (CVD) and all-cause mortality in older men. DESIGN: Prospective cohort study.
Atkins, JL, Lennon, LT, Morris, RW, Papacosta, O, Wannamethee, SG, Whincup, PH   +5 more
core   +1 more source

Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation [PDF]

, 2016
BACKGROUND: Experimental studies demonstrated that glutathione peroxidase 3 (GPx3), an antioxidant enzyme that catabolizes hydrogen peroxide, protects against thrombosis. Little is known about its role in cardiovascular disease. METHODS AND RESULTS:
Carnevale, Roberto, Farcomeni, Alessio, Menichelli, Danilo, Nocella, Cristina, Pastori, Daniele, Pignatelli, Pasquale, Violi, Francesco   +6 more
core   +1 more source

The influence of physical activity performed at 20-40 years of age on cardiovascular outcomes in medical patients aged 65-75

Italian Journal of Medicine, 2013
Introduction: Several studies show that physical activity can reduce the risk of cardiovascular disease, but the vast majority of these focus on the short- to intermediate-term benefits or refer to very specific populations.
Francesco Cipollini, Gualberto Gussoni, Roberta Pacifici, Silvia Rossi, Erminio Bonizzoni, Antonella Valerio, Adolfo Iacopino, Audenzio D’Angelo, Domenico Panuccio, Ido Iori, Antonino Mazzone, Piergiorgio Zuccaro, on behalf of the FADOI-ISS Study Group   +12 more
doaj   +1 more source